Regulatory News
Tuesday, August 30, 2016
BRIEF-Cempra says FDA scheduled meeting to discuss safety, efficacy of solithromycin
* FDA scheduled meeting of Antimicrobial Drugs Advisory
Committee on Nov. 4 to discuss safety, efficacy of solithromycin
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment